Cargando…
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Advances in chimeric antigen receptor (CAR)-T cell therapy have significantly improved clinical outcomes of patients with relapsed or refractory hematologic malignancies. However, progress is still hindered as clinical benefit is only available for a fraction of patients. A lack of understanding of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631149/ https://www.ncbi.nlm.nih.gov/pubmed/37941075 http://dx.doi.org/10.1186/s40779-023-00486-4 |